메뉴 건너뛰기




Volumn 16, Issue 5, 2005, Pages 379-382

The adherence to antiretroviral treatment evaluated from a hospital pharmacy: Importance of the protease inhibitors pharmacological class

Author keywords

Adherence; HIV patients; Hospital pharmacy; Protease inhibitor

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

EID: 18944370496     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462053888826     Document Type: Article
Times cited : (4)

References (8)
  • 1
    • 0032130263 scopus 로고    scopus 로고
    • Measuring HIV treatment adherence in clinical practice
    • Hecht FM. Measuring HIV treatment adherence in clinical practice. AIDS Clin Care 1998;10:57-9
    • (1998) AIDS Clin Care , vol.10 , pp. 57-59
    • Hecht, F.M.1
  • 3
    • 0033496346 scopus 로고    scopus 로고
    • Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
    • Singh N, Berman SM, Swindells S, et al. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 1999;29:824-30
    • (1999) Clin Infect Dis , vol.29 , pp. 824-830
    • Singh, N.1    Berman, S.M.2    Swindells, S.3
  • 4
    • 0034201607 scopus 로고    scopus 로고
    • Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients
    • Salmon-Ceron D, Deleuze J, Coste J, et al. Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients. Ann Med Interne 2000;151:297-302
    • (2000) Ann Med Interne , vol.151 , pp. 297-302
    • Salmon-Ceron, D.1    Deleuze, J.2    Coste, J.3
  • 6
    • 0033847883 scopus 로고    scopus 로고
    • Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients
    • Molina JM, Ferchal F, Rancinan C, et al. Once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus-infected patients. J Infect Dis 2000;182:599-602
    • (2000) J Infect Dis , vol.182 , pp. 599-602
    • Molina, J.M.1    Ferchal, F.2    Rancinan, C.3
  • 7
    • 0034639473 scopus 로고    scopus 로고
    • Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy
    • Descamps D, Flandre P, Calvez V, et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. JAMA 2000;283:205-11
    • (2000) JAMA , vol.283 , pp. 205-211
    • Descamps, D.1    Flandre, P.2    Calvez, V.3
  • 8
    • 0037016424 scopus 로고    scopus 로고
    • Predictors of virological rebound in HIV-1 infected patients initiating a protease inhibitor containing regimen
    • Le Moing V, Chêne G, Carrieri MP, et al. Predictors of virological rebound in HIV-1 infected patients initiating a protease inhibitor containing regimen. AIDS 2002;16:21-9
    • (2002) AIDS , vol.16 , pp. 21-29
    • Le Moing, V.1    Chêne, G.2    Carrieri, M.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.